Navigation Links
Clinical Trial Data (Phase 2a) Regarding Inhaled Amikacin Will Be,Presented at American Thoracic Society International Conference

and clinical trials are long, expensive and uncertain processes, (ii) because the NKTR-061 program is in the early phases of clinical development, the risk of failure is high and can occur at any stage of development, (iii) the company's ability to obtain regulatory approval of NKTR-061 and (iv) there can be no assurance that the company's patent applications for NTKR-061 will issue; patents that have issued will be enforceable; or that intellectual property licenses from third parties may not be required in the future. Other important risks and uncertainties are detailed in the company's reports and other filings with the SEC, including its most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q. Actual results could differ materially from the forward-looking statements contained in this press release. The company undertakes no obligation to update forward-looking statements, whether as a result of new information, future events, or otherwise.

Contact

Nektar
Tim Warner, 650-283-4915
twarner@nektar.com
or
Stephan Herrera, 415-488-7699
sherrera@nektar.com


'"/>




Page: 1 2 3

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference

Post Your Comments:
(Date:11/23/2009)...wswire-FirstCall/--Amgen(Nasdaq: AMGN )washonoredw...eandforBestNewDrugforNplate®(romiplostim),ata...neawardwaspresentedtoAmgenbyScripinrecognitionofth...y,spipeline,aswellasitsmixofcandidatesacrossdevelo...notableforitsfocusonunmetclinicalneed. ,, "Wear...
(Date:11/23/2009)...ortlinker.comannouncesthatanewmarketresearchreport...agnosticImagingMarketto2015 ,, http://www.re...ic-Imaging-Market-to-2015.html#utm_source=prnewswi... ,, Description ,, TheFutureoftheDiagnos...lMarketsDirect,s"TheFutureoftheDiagnosticImagingMa...
(Date:11/23/2009)...ortlinker.comannouncesthatanewmarketresearchreport...SandEMR ,, http://www.reportlinker.com/p0164...ewswire&utm_medium=pr&utm_campaign=prnewsw...most$1.3billion,representinganincreaseof6.7%over20...ediumhospitals(201-499beds),communityhospitals(200...
Breaking Medicine Technology:Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 3Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 4Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 5Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 6Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 2Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 3Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 4Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 5Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 6Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 7Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 8Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 9Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 10Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 11Reportlinker Adds U.S. Market for PACS and EMR 2Reportlinker Adds U.S. Market for PACS and EMR 3Reportlinker Adds U.S. Market for PACS and EMR 4Reportlinker Adds U.S. Market for PACS and EMR 5Reportlinker Adds U.S. Market for PACS and EMR 6Reportlinker Adds U.S. Market for PACS and EMR 7Reportlinker Adds U.S. Market for PACS and EMR 8Reportlinker Adds U.S. Market for PACS and EMR 9Reportlinker Adds U.S. Market for PACS and EMR 10Reportlinker Adds U.S. Market for PACS and EMR 11Reportlinker Adds U.S. Market for PACS and EMR 12Reportlinker Adds U.S. Market for PACS and EMR 13Kent State receives 242 7 million NSF training grant for environmental aquatic resource sensing 10643 1Kent State receives 242 7 million NSF training grant for environmental aquatic resource sensing 10643 2Doctors Point Out Gaps in U S Health Care 60776 1Doctors Point Out Gaps in U S Health Care 60776 2Practical Nursing Still a Growth Area in BC 60772 1Practical Nursing Still a Growth Area in BC 60772 2
...nced Cancer Patients, ROCKVILLE, Md., Dec. 4 Ent...rmaceutical company developing,therapeutics for th...oday,announced that it has commenced a multi-cente...th advanced pancreatic cancer. The primary objecti...or activity of,orally-administered MKC-1 in unrese...
...aluated Infrequent Dosing of Ustekinumab ...Pa. and BEERSE, Belgium, Dec. 4 Centocor, Inc.,an...hat regulatory,applications have been submitted re...n the United States and Europe for the treatment o...laque psoriasis. Centocor has,submitted a Biologic...
Other Medicine Technology:EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer 2EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer 3EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer 4Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis 2Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis 3
(Date:11/23/2009)...OKEN, N.J. The Center for Science Writings at Ste...lution of God," a talk by Robert Wright, journalis...er 2, 2009, 4:00-5:30 p.m. at the Babbio Center fo...ee and open to the public and the media., In his...journalist Robert Wright, renowned for his popular...
(Date:11/23/2009)...ARLINGTON, Va. The Infectious Diseases Society of...e Obama administration and the European Union to f...pment of 10 new antibiotics within the next 10 yea...ealth Organization (WHO) has identified antimicrob...s to human health. , A new European Union report...
(Date:11/23/2009)... iCRco is proud to announce it... KLAS and received the highest grade possible amon...ufacturer to be rated “A” in sales, se...stomer satisfaction in software functionality. iCR...hest grade by the most prestigious research firm i...
(Date:11/23/2009)..., ALEXANDRIA,Va.,Nov.23/PRNewswire/--Justintimefo...ovideshomechefswithtipsandrecipesforcookingupadeli...gcurrentnewsandhealthinformation, turkeyfrying.ne...nfriedturkeyaswellaspartyideasfortakingtheturkeybe...eauthenticallySouthernwayofdeep-fryingwith100%pean...
(Date:11/23/2009)...t says findings support link between mental and ph...hDay News) -- Being depressed might take as many y...ggests. , However, a combination of depression ...n just depression. , Researchers came to their ...rvey of more than 60,000 people. During the four y...
Breaking Medicine News(10 mins):Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 3Health News:iCRco is the Only CR Vendor to Receive the Highest Grade “A” in All Fields by KLAS 2Health News:iCRco is the Only CR Vendor to Receive the Highest Grade “A” in All Fields by KLAS 3Health News:Depression May Up Death Risk to That of Smoking 2
...ational AIDS Control Organisation with support fro...and National Institute of Medical Statistics (ICMR...ng high-risk populations, STI patients and Antenat...revalence among antenatal mothers has been observe...
...nly used drugs that are used in treatment of cance... determined by a research, published by the Journa...therapy can result in brain damage. The effects ma... patients. Cancer survivors, even after months hav...
...rug Controller General of India has recently appro...atment of Kala-azar patients.// The clinical ...ted by Indian Council of Medical Research, New Del... first line of treatment. The Government o...
...e are becoming exceedingly health conscious thus t...cohol among the UK population. It’s a known fact t...risk of heart ailments but it’s not very safe for ... My recommendations are for moderate drinking – wi...
...er Nancy Burton of Mount Maunganui, who faced char...prescription items has been found guilty .The tria...tion was conducted by the Ministry of Health and t...he Bay of Plenty District Health Board. Quen...
...oluntary Counseling and Testing (VCT) program in S... financial year between April 2005 and March 2006,... people tested has almost doubled as compared to l...among those who were tested were found to be HIV p...
Other Medicine News:
Body Suit w/Bra knee length
Compression Vest V-640
Male Compression Vests
Female Compression VEST w/sleeves
Medicine Products: